10030-73-6
10030-73-6 結(jié)構(gòu)式
基本信息
反式-棕櫚油酸
十六碳烯酸(反-9)
反式-9-十六碳烯酸
(9E)-9-十六烯酸
C16:1 (TRANS-9) ACID
(e)-9-hexadecenoicaci
(E)-9-Hexadecenoicacid
PALMITELAIDIC ACID 99%
trans-palmitoleic acid
(9E)-9-Hexadecenoicacid
(9E)-Hexadec-9-enoic acid
TRANS-9-HEXADECENOIC ACID
9-trans-Hexadecenoic acid
物理化學(xué)性質(zhì)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/05 | HY-N2341 | (9E)-9-十六烯酸 Palmitelaidic Acid | 10030-73-6 | 10mg(393mM * 100μL in Ethanol) | 500元 |
| 2026/06/05 | HY-N2341 | (9E)-9-十六烯酸 Palmitelaidic Acid | 10030-73-6 | 25 mg (393 mM * 250 μL in Ethanol) | 1000元 |
| 2026/06/05 | HY-N2341 | (9E)-9-十六烯酸 Palmitelaidic Acid | 10030-73-6 | 50 mg (393 mM * 500 μL in Ethanol) | 1600元 |
常見問題列表
|
AMPK
|
PPARα
|
Glucokinase
|
The monounsaturated fatty acid palmitoleate (palmitoleic acid) is one of the most abundant fatty acids in serum and tissues, particularly adipose tissue and liver. Its endogenous production by stearoyl-CoA desaturase 1 gives rise to its cis isoform, cis-palmitoleate. Palmitoleic acid has been correlated with multiple cardiometabolic risk factors, including high blood pressure, total cholesterol, TGs, apoA-I, apoB, and endothelial dysfunction.
Palmitoleic acid promotes a faster uptake of glucose in the body, associated with higher insulin concentration. Palmitoleic acid increases the phosphorylation of AMPK, up-regulates glucokinase and down-regulates SREBP-1. Regarding AMPK downstream, palmitoleic acid increases the production of FGF-21 and stimulates the expression of PPARα. Palmitoleic acid reduces body weight increase, ameliorates the development of hyperglycemia and hypertriglyceridemia, and improves insulin sensitivity. Furthermore, palmitoleic acid down-regulates mRNA expressions of proinflammatory adipocytokine genes (TNFα and resistin) in white adipose tissue and lipogenic genes (SREBP-1, FAS, and SCD-1) in liver.